JWH 133

• Supplier: R&D Systems
• Catalog: 1343
• Prices: $249.00
• Sizes: 10 mg
• Cas Number: 259869-55-1
• Chemical Name: (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
• Formula: C22H32O
• Molecular Weight: 312.49
• Purity: >98%

Product References

Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced - Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced

Huang Z, Wang H, Wang J, Zhao M, Sun N, Sun F, Shen J, Zhang H, Xia K, Chen D, Gao M, Hammer RP, Liu Q, Xi Z, Fan X, Wu J. Sci Rep. 2016 Jul 19;6:29757.

Correlations between the Memory-Related Behavior and the Level of Oxidative - Correlations between the Memory-Related Behavior and the Level of Oxidative

Kruk-Slomka M, Boguszewska-Czubara A, Slomka T, Budzynska B, Biala G. Neural Plast. 2016;2016:9815092.

Pharmacological activation of CB2 receptors counteracts the deleterious effect of - Pharmacological activation of CB2 receptors counteracts the deleterious effect of

Rivera P, Blanco E, Bindila L, Alen F, Vargas A, Rubio L, Pavon FJ, Serrano A, Lutz B, Rodriguez de Fonseca F, Suarez J. Front Cell Neurosci. 2015 Sep 29;9:379.

Regional effects of endocannabinoid, BDNF and FGF receptor signalling on - Regional effects of endocannabinoid, BDNF and FGF receptor signalling on

Zhou Y, Oudin MJ, Gajendra S, Sonego M, Falenta K, Williams G, Lalli G, Doherty P. Mol Cell Neurosci. 2015 Jan;64:32-43.

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse - Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse

Presley C, Abidi A, Suryawanshi S, Mustafa S, Meibohm B, Moore BM. Pharmacol Res Perspect. 2015 Aug;3(4):e00159.

A cannabigerol derivative suppresses immune responses and protects mice from - A cannabigerol derivative suppresses immune responses and protects mice from

Carrillo-Salinas FJ, Navarrete C, Mecha M, Feliu A, Collado JA, Cantarero I, Bellido ML, Munoz E, Guaza C. PLoS One. 2014 Apr 11;9(4):e94733.

Delta(9)-Tetrahydrocannabinol treatment during human monocyte differentiation - Delta(9)-Tetrahydrocannabinol treatment during human monocyte differentiation

Williams JC, Appelberg S, Goldberger BA, Klein TW, Sleasman JW, Goodenow MM. J Neuroimmune Pharmacol. 2014 Jun;9(3):369-79.

Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the - Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the

Amenta PS, Jallo JI, Tuma RF, Hooper DC, Elliott MB. J Neuroinflammation. 2014 Nov 22;11:191.

CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin - CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin

Malenczyk K, Jazurek M, Keimpema E, Silvestri C, Janikiewicz J, Mackie K, Di Marzo V, Redowicz MJ, Harkany T, Dobrzyn A. J Biol Chem. 2013 Nov 8;288(45):32685-99.

Treatment with CB2 agonist JWH-133 reduces histological features associated with - Treatment with CB2 agonist JWH-133 reduces histological features associated with

Fraga-Silva RA, Costa-Fraga FP, Montecucco F, Faye Y, Savergnini SQ, Lenglet S, Mach F, Steffens S, Stergiopulos N, dos Santos RA, da Silva RF. Clin Dev Immunol. 2013;2013:263846.